Transapical Aortic Valve Implantation in High-Risk Patients With Severe Aortic Valve Stenosis Augusto D'Onofrio, MD, Melissa Fusari, MD, Nicola Abbiate, MD, Chiara Zanchettin, MD, Roberto Bianco, MD, Alessandro Fabbri, MD, Loris Salvador, MD, Elvio Polesel, MD, Paolo Biglioli, MD, Gino Gerosa, MD The Annals of Thoracic Surgery Volume 92, Issue 5, Pages 1671-1677 (November 2011) DOI: 10.1016/j.athoracsur.2011.06.005 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Two-year Kaplan-Meier survival of 179 patients after transapical aortic valve implantation. (TAVI = transcatheter aortic valve implantation.) The Annals of Thoracic Surgery 2011 92, 1671-1677DOI: (10.1016/j.athoracsur.2011.06.005) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Two-year Kaplan-Meier survival in the first 50% (continuous line) and the second 50% (interrupted line) patients of each center. (TA-TAVI = transapical aortic valve implantation.) The Annals of Thoracic Surgery 2011 92, 1671-1677DOI: (10.1016/j.athoracsur.2011.06.005) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Two-year Kaplan-Meier survival of patients with and without intraoperative complications. (TA-TAVI = transapical aortic valve implantation.) The Annals of Thoracic Surgery 2011 92, 1671-1677DOI: (10.1016/j.athoracsur.2011.06.005) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions